Table 2

ORs for the risk of DIC in each study population*

Study population A (overall population)Study population B (laboratory data-available admissions only)
non-DMT2DMnon-DMT2DM
All
 Number of admission306 100260 091259 63353 793
 Number of DIC3287 (1.1%)4640 (1.8%)821 (0.3%)307 (0.6%)
 Age, sex and admission year-adjusted OR11.60 (1.52 to 1.67)11.63 (1.43 to 1.87)
 Further adjusting for underlying diseases11.39 (1.32 to 1.45)11.28 (1.11 to 1.47)
By underlying disease
Sepsis
 Number of admission5 005921135241611
 Number of DIC920 (18.4%)1 618 (17.6%)335 (9.5%)125 (7.8%)
 Age, sex and admission year-adjusted OR10.97 (0.88 to 1.06)10.79 (0.64 to 0.99)
 Further adjusting for underlying diseases10.98 (0.90 to 1.08)10.81 (0.65 to 1.01)
Non-septic severe infection
 Number of admission17 11817 93114 5413681
 Number of DIC226 (1.3%)527 (2.9%)73 (0.5%)47 (1.3%)
 Age, sex and admission year-adjusted OR12.05 (1.75 to 2.41)12.11 (1.44 to 3.07)
 Further adjusting for underlying diseases11.67 (1.41 to 1.97)11.56 (1.05 to 2.30)
Solid tumour
 Number of admission111 90882 30596 39819 127
 Number of DIC1 207 (1.1%)1 645 (2.0%)302 (0.3%)115 (0.6%)
 Age, sex and admission year-adjusted OR11.89 (1.75 to 2.04)11.93 (1.55 to 2.40)
 Further adjusting for underlying diseases11.59 (1.47 to 1.72)11.46 (1.16 to 1.83)
Acute leukaemia
 Number of admission1 8091 6041 148386
 Number of DIC451 (24.9%)284 (17.7%)166 (14.5%)33 (8.5%)
 Age, sex and admission year-adjusted OR10.73 (0.61 to 0.86)10.57 (0.38 to 0.84)
 Further adjusting for underlying diseases10.70 (0.59 to 0.84)10.58 (0.39 to 0.87)
  • Adjustment variables were age (continuous), sex (male or female), admission year (<2011, 2011, 2012, 2013 or 2014) and underlying diseases (sepsis, non-septic severe infection, solid tumour and acute leukaemia; yes or no, for each).

  • *DIC was defined based on the physician's diagnosis of DIC only in study population A, and the physician's diagnosis of DIC with supporting laboratory data in study population B.

  • DIC, disseminated intravascular coagulation; T2DM, type 2 diabetes mellitus.